Evidence map›Paper›PMID 24002251›Full record

ReviewNature reviews. Neuroscience2013

p11 and its role in depression and therapeutic responses to antidepressants.

Per Svenningsson, Yong Kim, Jennifer Warner-Schmidt, Yong-Seok Oh, Paul Greengard

Abstract readReview
In one paragraph

Review in Nature reviews. Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Genetic alterations in SUPT6H are associated with neurodevelopmental disorders.Biochimica et biophysica acta. Molecular basis of disease · 2026
    Article
  4. Article
  5. Low 5HTJournal of neurochemistry · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. A molecular mechanism mediating clozapine-enhanced sensorimotor gating.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Per Svenningsson
Yong Kim
Jennifer Warner-Schmidt
Yong-Seok Oh
Paul Greengard

Funding

Striatal Cell-specific Analysis of the Molecular Mechanisms of Antipsychotic DrugP50MH090963 · NIMH · ROCKEFELLER UNIVERSITY · PI NESTLER, ERIC J. · 2010 to 2014
$9.8M
Translational and epigenetic profiling of cell types associated with addictionRC2DA028968 · NIDA · ROCKEFELLER UNIVERSITY · PI HEINTZ, NATHANIEL · 2009 to 2010
$4.6M
NIDA NIH HHS 1RC2DA028968NIDA NIH HHS RC2 DA028968NIMH NIH HHS MH090963NIMH NIH HHS P50 MH090963
6 · The paper itself

Abstract

Studies of the multifunctional protein p11 (also known as S100A10) are shedding light on the molecular and cellular mechanisms underlying depression. Here, we review data implicating p11 in both the amplification of serotonergic signalling and the regulation of gene transcription. We summarize studies demonstrating that levels of p11 are regulated in depression and by antidepressant regimens and, conversely, that p11 regulates depression-like behaviours and/or responses to antidepressants. Current and future studies of p11 may provide a molecular and cellular framework for the development of novel antidepressant therapies.

Indexed as

AnimalsAnnexin A2Antidepressive AgentsBrainDepressionDisease Models, AnimalGene Expression RegulationHumansS100 Calcium Binding Protein A10S100 ProteinsAnnexin A2Antidepressive AgentsS100 Calcium Binding Protein A10S100 Proteins

Identifiers

PMID24002251
PMCPMC3933996

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.